# LEADERS FREE II: BioFreedom™ Pivotal Study

Study · id `cardio:ct-nct02843633` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02843633](<https://clinicaltrials.gov/study/NCT02843633>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02843633

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1203 participants.

## Technical summary

Registry record NCT02843633. Allocation not applicable; no masking; primary purpose treatment. Start 2017-02-14 (actual); primary completion 2018-10-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1203 participants (enrolled count; ClinicalTrials.gov record NCT02843633, source copy `cardio:ctgov-nct02843633-2021-02-03`, retrieved 2026-10-31)
- Started: 2017-02-14 (actual) (ClinicalTrials.gov record NCT02843633, source copy `cardio:ctgov-nct02843633-2021-02-03`, retrieved 2026-10-31)
- Primary completion: 2018-10-11 (actual) (ClinicalTrials.gov record NCT02843633, source copy `cardio:ctgov-nct02843633-2021-02-03`, retrieved 2026-10-31)
- Completion: 2021-03 (anticipated) (ClinicalTrials.gov record NCT02843633, source copy `cardio:ctgov-nct02843633-2021-02-03`, retrieved 2026-10-31)
- Countries: United States; Canada; Denmark; France; Germany; Italy; United Kingdom (ClinicalTrials.gov record NCT02843633, source copy `cardio:ctgov-nct02843633-2021-02-03`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02843633-2021-02-03`, retrieved 2026-10-31)

## The registry's words

- Brief title: LEADERS FREE II: BioFreedom™ Pivotal Study
- Condition: Acute Coronary Syndrome
- Condition: High Bleeding Risk
- Intervention (Device): BioFreedom™ Drug Coated Coronary Stent System
- Intervention (Drug): Antiplatelet Drug
- Lead sponsor: Biosensors Europe SA
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: Biosensors Europe SA (`cardio:org-biosensors-europe-sa`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Sex-Based Outcomes in Patients With a High Bleeding Risk After Percutaneous Coronary Intervention and 1-Month Dual Antiplatelet Therapy: A Secondary Analysis of the LEADERS FREE Randomized Clinical Trial (`cardio:pubmed-32432718`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 6ec44d4a47a6c6ce6ca7953b86e67c1912bd605c432c0cc6f1e5ecdf0d5c070a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
